TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9680679

Group type: EXPERIMENTAL
Intervention: Low inhibitory control conditions (e.g., misleading pictorial cues or arrows)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: High inhibitory control conditions (deceptive pointing)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Anonymous and public conditions using an arrow to deceive
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Well-controlled conditions for deceptive and nondeceptive tasks
Number of subjects: 3
Study: 8021037

Group type: EXPERIMENTAL
Intervention: 0.4% SnF2 gel (n = 30) used twice daily for 18 months
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 0.05% NaF rinse (n = 30) used with 1100 ppm F toothpaste
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (n = 35) using only standard fluoride (1100 ppm F) toothpaste
Number of subjects: 95
Study: 2681637

Group type: EXPERIMENTAL
Intervention: Recombinant somatropin, 0.1 mg/kg three times a week
Number of subjects: 121

Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 121
Study: 30270047

Group type: EXPERIMENTAL
Intervention: Oral acetaminophen administered within 1 hour of induction
Number of subjects: 37

Group type: COMPARATOR
Intervention: Fasting (control group)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Oral acetaminophen (treatment group)
Number of subjects: 37
Study: 29066159

Group type: EXPERIMENTAL
Intervention: n‐3 long‐chain polyunsaturated fatty acids (LCPUFA) 4 g/d for three months
Number of subjects: 422

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: n‐3 LCPUFA
Number of subjects: 422
Study: 26287149

Group type: EXPERIMENTAL
Intervention: Carboxymethyl-glucan (CM-G) administered orally for 60 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23003110

Group type: EXPERIMENTAL
Intervention: Bipolar plasmakinetic energy transurethral resection of the bladder
Number of subjects: 132

Group type: COMPARATOR
Intervention: Conventional monopolar transurethral resection of the bladder
Number of subjects: 132
Study: 21429334

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (n = 32)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Medical treatment (n = 32)
Number of subjects: 64
Study: 18657806

Group type: COMPARATOR
Intervention: Endoscopic SEMS
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Percutaneous SEMS
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both groups (successful biliary drainage)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both groups (after successful biliary decompression)
Number of subjects: 85
Study: 17407369

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (50 or 100 mg doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15065981

Group type: EXPERIMENTAL
Intervention: Sequential lineup with absolute height encoding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simultaneous lineup with relative height encoding
Number of subjects: 0
Study: 11731354

Group type: EXPERIMENTAL
Intervention: Fluoxetine 10 mg daily for 1 week, then increased to 20 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9272346

Group type: EXPERIMENTAL
Intervention: Acellular vaccines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole-cell vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 7840402

Group type: EXPERIMENTAL
Intervention: Ketamine anaesthesia (n = 20)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: General intubation anaesthesia (n = 18)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No anaesthesia (Control group, n = 16)
Number of subjects: 54
Study: 2736427

Group type: EXPERIMENTAL
Intervention: Base product plus sunset yellow/tartrazine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Base product plus sodium metabisulphite/sodium benzoate
Number of subjects: 19

Group type: COMPARATOR
Intervention: Base product alone (placebo)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Base product alone, base product plus sunset yellow/tartrazine, base product plus sodium metabisulphite/sodium benzoate
Number of subjects: 19
Study: 1093429

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (without PEEP)
Number of subjects: 7
Study: 31252090

Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation (MM)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Cognitive Therapy (CT)
Number of subjects: 69
Study: 29958013

Group type: EXPERIMENTAL
Intervention: Fear appeal messages with high threat and efficacy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fear arousal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blunting coping style
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitoring coping style
Number of subjects: 0
Study: 28315481

Group type: EXPERIMENTAL
Intervention: Patient Advocate (PA) intervention
Number of subjects: 312

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 312
Study: 25398562

Group type: EXPERIMENTAL
Intervention: Very low nicotine content (VLNC) cigarettes provided for 12 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (usual cigarette brand)
Number of subjects: 33
Study: 24622005

Group type: EXPERIMENTAL
Intervention: ASCEND-HF trial patients (Nesiritide treatment)
Number of subjects: 3149

Group type: COMPARATOR
Intervention: Population-level cohorts (not specified treatment)
Number of subjects: 3149
Study: 16526312

Group type: EXPERIMENTAL
Intervention: Oral bicarbonate therapy (1.2 mEq/kg of body weight daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12707480

Group type: EXPERIMENTAL
Intervention: Supportive-expressive group intervention (GI)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Educational control condition (EC)
Number of subjects: 85
Study: 10628543

Group type: EXPERIMENTAL
Intervention: Tonsillotomy (TT) with CO2-laser
Number of subjects: 41

Group type: COMPARATOR
Intervention: Tonsillectomy (TE)
Number of subjects: 41
Study: 7853949

Group type: EXPERIMENTAL
Intervention: Social services case-management
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study: 1750016

Group type: EXPERIMENTAL
Intervention: Nasal sprays of recombinant alpha 2 interferon (3 x 10(6) IU) twice daily for five days
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo twice daily for five days
Number of subjects: 123
Study: 6285281

Group type: EXPERIMENTAL
Intervention: Isaxonine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30820429

Group type: EXPERIMENTAL
Intervention: Incise drape (ID) used in treatment group
Number of subjects: 88
Study: 29099872

Group type: EXPERIMENTAL
Intervention: EKG heart rate displayed to clinical team
Number of subjects: 40

Group type: COMPARATOR
Intervention: EKG heart rate not displayed to clinical team
Number of subjects: 40
Study: 25429384

Group type: EXPERIMENTAL
Intervention: High maternal milk feeds (MMFs) at second week
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Maternal age
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Assisted reproduction technology
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Employment
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Nonuniversity education
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Non‐Nordic origin
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Overweight
Number of subjects: 97
Study: 23311304

Group type: EXPERIMENTAL
Intervention: Cogmed computerized working memory training
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Paying attention in class intervention (experimental school-based executive function training)
Number of subjects: 100
Study: 20848500

Group type: EXPERIMENTAL
Intervention: Open-label adalimumab weekly therapy
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Open-label adalimumab EOW therapy
Number of subjects: 260

Group type: COMPARATOR
Intervention: Blinded adalimumab EOW therapy
Number of subjects: 260
Study: 18435189

Group type: EXPERIMENTAL
Intervention: AdheSe (ADH) with additional phosphoric acid etching
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Xeno III (XE) with additional phosphoric acid etching
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Futurabond NR (FNR) with additional phosphoric acid etching
Number of subjects: 70

Group type: COMPARATOR
Intervention: Futurabond NR (FNR) without additional phosphoric acid etching
Number of subjects: 70
Study: 16877490

Group type: EXPERIMENTAL
Intervention: Calcium salts (CaS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sevelamer
Number of subjects: 64
Study: 12806613

Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids (BCAA)
Number of subjects: 174
Study: 11034934

Group type: EXPERIMENTAL
Intervention: VLDL-apoB
Number of subjects: 4159

Group type: EXPERIMENTAL
Intervention: apoCIII in VLDL+LDL
Number of subjects: 4159

Group type: EXPERIMENTAL
Intervention: apoE in HDL
Number of subjects: 4159

Group type: EXPERIMENTAL
Intervention: Plasma triglycerides
Number of subjects: 4159
Study: 8660045

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (70 mg/kg given over 7 d)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Ofloxacin (45‐50 mg/kg given over 3‐5 d)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Control group (children who had not contracted typhoid or received any fluoroquinolones)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and Ofloxacin
Number of subjects: 326
Study: 1891222

Group type: EXPERIMENTAL
Intervention: Pneumatic retinopexy (PR)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Scleral buckling (SB)
Number of subjects: 179
Study: 6872416

Group type: EXPERIMENTAL
Intervention: Sublingual lorazepam 2 mg every 2 hr with supportive care (21 patients)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sublingual placebo every 2 hr with supportive care (20 patients)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups (21 drug group and 20 no-drug group)
Number of subjects: 41
Study: 31938818

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (3490 ± 1465 IU/day)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Vitamin D3 and Placebo
Number of subjects: 260
Study: 30703096

Group type: EXPERIMENTAL
Intervention: Mass deworming treatment
Number of subjects: 0
Study: 30270688

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2100 IE q.d. for 48 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26932178

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 300
Study: 24755106

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST) for 6 weeks from a licensed renal social worker
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 38
Study: 22318468

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1,200 mg daily for 6 weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2,400 mg daily for 6 weeks
Number of subjects: 11
Study: 19155337

Group type: EXPERIMENTAL
Intervention: Morning shift workers (Group I)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Afternoon shift workers (Group II)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Individuals working 12 hours (Group III)
Number of subjects: 70
Study: 17448578

Group type: EXPERIMENTAL
Intervention: Killed oral vaccine for enterotoxigenic E. coli (ETEC) diarrhoea, two doses with colonization factor antigens (CF) and cholera B subunit
Number of subjects: 672

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 672
Study: 15900094

Group type: EXPERIMENTAL
Intervention: Hemocoagulase in addition to mechanical ventilation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mechanical ventilation only
Number of subjects: 48
Study: 12421104

Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg/day as an adjunct to radiotherapy, radical prostatectomy or watchful waiting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg/day monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Castration (medical or surgical)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg/day
Number of subjects: 0
Study: 9708750

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (0.75 mg, repeated 12 h later)
Number of subjects: 1998

Group type: COMPARATOR
Intervention: Yuzpe regimen (ethinyloestradiol 100 microg plus levonorgestrel 0.5 mg, repeated 12 h later)
Number of subjects: 1998
Study: 8567563

Group type: EXPERIMENTAL
Intervention: Graded epinephrine infusion (0.02-0.12 micrograms.kg-1.min-1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control test (no epinephrine infusion)
Number of subjects: 8
Study: 2213379

Group type: EXPERIMENTAL
Intervention: Double-blind, placebo-controlled food challenge (DBPCFC)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Open challenges with large amounts of challenge food
Number of subjects: 480
Study: 352100

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 20

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 20
Study: 27364093

Group type: EXPERIMENTAL
Intervention: Soy nuts
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control food
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Equol + ODMA producers
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nonproducers
Number of subjects: 17
Study: 25769742

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 23865591

Group type: EXPERIMENTAL
Intervention: Hyoscine butylbromide (HBB) 20-100 mg/day
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 21843017

Group type: EXPERIMENTAL
Intervention: Fatigued individuals working alone
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Fatigued individuals working in teams
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Teams with a relatively less fatigued member
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Participants cued toward more direct strategies
Number of subjects: 171
Study: 19793466

Group type: EXPERIMENTAL
Intervention: Humidified-warm gas
Number of subjects: 113

Group type: COMPARATOR
Intervention: Dry-heated gas
Number of subjects: 113

Group type: COMPARATOR
Intervention: Traditional dry-cold gas
Number of subjects: 113
Study: 16696804

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG 18 x 10(9) viable bacteria/day
Number of subjects: 187

Group type: COMPARATOR
Intervention: mesalazine 2400 mg/day
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG + mesalazine
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG
Number of subjects: 187
Study: 14970966

Group type: EXPERIMENTAL
Intervention: Wheelchair Skills Training Program (WSTP), averaging 4.5+/‐1.5 training sessions, each 30 minutes long.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard rehabilitation program (control group).
Number of subjects: 35
Study: 11739977

Group type: EXPERIMENTAL
Intervention: Automated classification algorithm using dual-gate TCD and wavelet representation
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Automated classification algorithm for distinguishing solid from gaseous emboli
Number of subjects: 600
Study: 9118709

Group type: EXPERIMENTAL
Intervention: HMEF (Hygroster; DAR; Mirandola, Italy)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Water-bath humidifier heated at 32 degrees C (HWBH)
Number of subjects: 115
Study: 8437031

Group type: EXPERIMENTAL
Intervention: PASE by mail
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PASE by telephone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PASE scores
Number of subjects: 0
Study: 3741936

Group type: EXPERIMENTAL
Intervention: Androstenol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29117012

Group type: EXPERIMENTAL
Intervention: IV acetaminophen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 26764319

Group type: EXPERIMENTAL
Intervention: Usual bread-based lunch (UBL)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Hot lunch meal (HLM)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Plasma total ARs
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Reported WG intake
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: AR C17:0 homolog
Number of subjects: 750
Study: 24727258

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy
Number of subjects: 2397

Group type: EXPERIMENTAL
Intervention: Amiodarone therapy
Number of subjects: 2397

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 2397
Study: 21737565

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 206
Study: 20416554

Group type: EXPERIMENTAL
Intervention: Tooth Mousse
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ultra‐EZ
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Cervitec Plus
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ultra‐EZ/XP Bond
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control/AdheSE
Number of subjects: 160
Study: 18565598

Group type: EXPERIMENTAL
Intervention: Topical treatment (ear drops and saline solution)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical treatment with systemic antibiotics
Number of subjects: 50
Study: 16335787

Group type: EXPERIMENTAL
Intervention: Garlic pearls (GP) 250 mg per day for 2 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (normotensive subjects)
Number of subjects: 20
Study: 12464091

Group type: EXPERIMENTAL
Intervention: Cholecystokinin octapeptide (CCK‐OP) at 40 ng kg‐1 h‐1
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cholecystokinin octapeptide (CCK‐OP) at 5 or 20 ng kg‐1 h‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cholecystokinin octapeptide (CCK‐OP)
Number of subjects: 8
Study: 10505732

Group type: EXPERIMENTAL
Intervention: Sucralfate enemas (20 g/100 ml)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Methylprednisolone enemas (20 mg/100 ml)
Number of subjects: 60
Study: 8525039

Group type: EXPERIMENTAL
Intervention: Active labor management (study group, n = 75)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Traditional labor management (control group, n = 70)
Number of subjects: 145
Study: 2302053

Group type: EXPERIMENTAL
Intervention: Arm crank ergometer (ACE) exercise
Number of subjects: 9

Group type: COMPARATOR
Intervention: Wheelchair ergometer (WCE) exercise
Number of subjects: 9
Study: 7447412

Group type: EXPERIMENTAL
Intervention: Flucloxacillin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cloxacillin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Flucloxacillin and Cloxacillin (combined data)
Number of subjects: 54
Study: 6581065

Group type: EXPERIMENTAL
Intervention: Fenoterol powder for inhalation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fenoterol spray
Number of subjects: 20
Study: 31058628

Group type: EXPERIMENTAL
Intervention: Gutta-percha/AH Plus
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Resilon/Epiphany
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group II (not specified)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group IV (not specified)
Number of subjects: 60
Study: 29290053

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study: 27681016

Group type: EXPERIMENTAL
Intervention: Interdental brushes used daily with a standard manual toothbrush twice daily
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard manual toothbrush
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Interdental brushes
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Low baseline bleeding frequency
Number of subjects: 46
Study: 25503280

Group type: EXPERIMENTAL
Intervention: Six-week aerobic training program (running and rope skipping)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 22460297

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20207952

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 601

Group type: COMPARATOR
Intervention: Simvastatin 40 mg
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: CYP3A5 and/or BCRP variant genotypes
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: CYP2C9, CYP2C19, or SLCO1B1 variants
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Most common genotypes for CYP3A5 and BCRP
Number of subjects: 601
Study: 17507702

Group type: COMPARATOR
Intervention: Continued fluticasone (100 microg twice daily)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Fluticasone (100 microg) plus salmeterol (50 microg) each night
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Montelukast (5 or 10 mg each night)
Number of subjects: 500
Study: 15654254

Group type: EXPERIMENTAL
Intervention: Pericardial adipose tissue measurement using cardiac CT scans
Number of subjects: 80
Study: 12073204

Group type: EXPERIMENTAL
Intervention: Platelet pheresis
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (no platelet pheresis)
Number of subjects: 54
Study: 11552615

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment (10 procedures)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sonophoresis treatment (diclofenac gel, 10 procedures)
Number of subjects: 64
Study: 7768254

Group type: EXPERIMENTAL
Intervention: 2.5 mg ramipril orally
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2.5 mg ramipril intravenously
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2.5 mg ramiprilat intravenously
Number of subjects: 12
Study: 2283645

Group type: EXPERIMENTAL
Intervention: Diltiazem (60-180 mg twice daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Captopril (25-75 mg twice daily)
Number of subjects: 48
Study: 465123

Group type: COMPARATOR
Intervention: Exercise (E)
Number of subjects: 11